Does ELOTUZUMAB Cause Lymphopenia? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Lymphopenia have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 0.4% of all adverse event reports for ELOTUZUMAB.
15
Reports of Lymphopenia with ELOTUZUMAB
0.4%
of all ELOTUZUMAB reports
9
Deaths
2
Hospitalizations
How Dangerous Is Lymphopenia From ELOTUZUMAB?
Of the 15 reports, 9 (60.0%) resulted in death, 2 (13.3%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Lymphopenia Listed in the Official Label?
Yes, Lymphopenia is listed as a known adverse reaction in the official FDA drug label for ELOTUZUMAB.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Thrombocytopenia (107)
Diarrhoea (105)
What Other Drugs Cause Lymphopenia?
FINGOLIMOD (1,515)
CYCLOPHOSPHAMIDE (952)
RITUXIMAB (932)
DEXAMETHASONE (814)
PREDNISONE (788)
DIMETHYL (598)
METHOTREXATE (549)
PREDNISOLONE (465)
TACROLIMUS (456)
MYCOPHENOLATE MOFETIL (453)
Which ELOTUZUMAB Alternatives Have Lower Lymphopenia Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE